Asston Pharmaceuticals Limited Press Release Sep 05 2026

Summary by 6ix AI

Asston Pharmaceuticals Limited has announced the outcome of its Board Meeting regarding the allotment of shares. The Board approved the issuance of a significant number of equity shares at a specified price, including a premium. This allotment will increase the company's paid-up equity share capital, reflecting the new total number of equity shares. The filing includes details required under SEBI regulations, including the type of securities and issuance method.

Written by 6ix AI from the company’s filing. How 6ix writes summaries